The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the Offering VANCOUVER, British Columbia, Nov. 27, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company” or
The Company has received initial commitments totaling over $800,000 from strategic investors in connection with the Offering Read More
